Latest Global Markets News

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

CleanSpace's AGILE respirator has achieved AS/NZS 17420.2:2021 certification, paving the way for commercialisation in Australia and New Zealand alongside its recent European approval.

ClearVue Technologies has secured A$6 million through a $5 million institutional placement and a fully underwritten $1 million Share Purchase Plan, aiming to bolster its balance sheet and fund international expansion and product development.

Fenix Resources has partnered with Mira Bulk to reduce iron ore shipping costs and secured US$44 million in long-term funding, underpinning its production ramp-up to 6 million tonnes by FY28.

Australian Agricultural Company (ASX:AAC) defied North Queensland floods to deliver a 23% jump in operating profit, driven by strong beef pricing and herd valuation gains.

BCAL Diagnostics has developed BREASTEST Monitor, a blood test showing promising accuracy in detecting local breast cancer recurrence in women over 50, aiming to simplify post-treatment monitoring.

Precinct Properties has struck a $600 million deal to sell a 50% stake in Auckland’s PwC Tower to PAG, cutting its gearing to a lean 24% and setting the stage for future growth.

GCM Corporation expands its VHD heat sink portfolio to 44 products and moves into liquid cooling OEM markets for AI servers, securing global distribution via DigiKey.

Brazilian Critical Minerals (ASX: BCM) has cleared a major regulatory hurdle as Brazil's Federal Mines Agency approves the final exploration reports for its Ema rare earth project, paving the way for mining license applications and further development.

ASX has settled ASIC proceedings over 2022 statements on its previous CHESS project, admitting to misleading the market with a 'progressing well' claim. The settlement includes a $20.5 million penalty and $3 million in legal cost contributions, pending Federal Court approval.

Develop Global has greenlit major investments in its Sulphur Springs copper-zinc and Pioneer Dome lithium projects, backed by a US$400 million financing and offtake deal with Trafigura that also refinances Woodlawn.

Biome Australia has inked a binding deal with Specialty Probiotics Australia to shift its Activated Probiotics manufacturing onshore, aiming to boost gross margins above 65% and streamline working capital within 18 months.